VerifiedFact Checked
Can taking weight loss injections lower your risk of getting dementia?

Can taking weight loss injections lower your risk of getting dementia?

Weight loss injections like Wegovy contain GLP-1 receptor agonists (GLP-1 RAs), which show promising results for brain health. Research shows that GLP-1 RAs can protect brain cells, improve blood flow to the brain, and possibly slow disease progression.

Alexandra Cristina Cowell
Medically reviewed by
Alexandra Cristina Cowell, Writer & Clinical Content Reviewer

Although GLP-1 RAs aren’t approved for dementia, emerging research shows their therapeutic potential for neurodegenerative diseases.

Go to
Medically reviewed by
Dr Alexandra Cristina Cowell
Writer & Clinical Content Reviewer
on May 02, 2025.
Meet Alexandra Cristina  
Alexandra Cristina

Last updated on Dec 12, 2025.

Was this article useful?

Summary:

  • GLP-1 RA drugs may protect the brain, reduce inflammation, and slow dementia-related disease progression.
  • In Alzheimer’s, GLP-1 RAs may cut amyloid plaques, support neurons, and ease symptoms.
  • In Parkinson’s disease, these drugs may protect dopamine-producing neurons and improve motor function, though evidence is still limited and inconclusive
  • GLP-1s aren’t approved for dementia yet, but research suggests strong potential for future use in brain health.

How can weight loss injections help with neurodegenerative diseases?

Neurodegenerative diseases (ND) like Alzheimer’s and Parkinson’s disease affect your nerve cells, often leading to a decline in cognitive function. There’s no cure for these diseases, instead, treatments aim to slow disease progression and improve quality of life.

Weight loss injections (like Wegovy, Ozempic and Zepbound) have been in the spotlight for their weight loss results and proven ability to manage blood sugar levels. They mimic the hormone GLP-1, which your body naturally releases after eating to signal your brain that you’re full and satisfied.

In addition to weight loss, recent research shows GLP-1’s neuroprotective properties might be able to prevent nerve cell damage and death.

How GLP-1s help with insulin resistance

Insulin resistance is when your body doesn’t respond to insulin effectively, which leads to uncontrolled blood sugar levels and the development of type 2 diabetes.

But more than this, insulin resistance can damage your brain too, contributing to ND. Your brain needs insulin to create new neuronal connections to support memory and learning, and without it, inflammation can increase, damaging neurons, affecting your memory and ability to function.

GLP-1 RAs can enhance insulin sensitivity, which may improve cognitive function. It also has anti-inflammatory properties that may help reduce brain inflammation and slow the progression of ND.

How GLP-1s could help neuronal survival

GLP-1s have been shown to have neuroprotective properties, including:

  • Reducing nerve cell death, which prevents cognitive decline.
  • Promoting the growth of neurons to help build new connections.
  • Improving motor and sensory function.
  • Decreasing brain inflammation.
  • Increasing blood flow to the brain to provide essential nutrients and oxygen.

These mechanisms may help neurons survive and improve overall brain function. As a result, GLP-1 agonist medications may also help to bring about these benefits (by performing the same functions within your body).

How GLP-1s help neuronal inflammation

Brain inflammation plays a key role in the development of ND. Although inflammation can be a neuroprotective property, chronic inflammation can cause neuronal damage and death.

Brain inflammation is believed to be caused by amyloid plaques, which are a hallmark of Alzheimer's disease (AD).

Studies show that GLP-1 has anti-inflammatory effects, reduces the accumulation of amyloid plaque, and enhances memory function.

How can weight loss injections help Alzheimer's disease?

Alzheimer’s disease (AD) is the most common type of dementia. In the United States, an estimated 6.9 million people aged 65 and older are living with the condition. The symptoms may include poor judgment, trouble thinking, memory issues, confusion and personality changes. There’s no cure for AD, but treatments can slow the progression.

Although this hasn’t been proven in humans yet, GLP-1 RA may reduce the buildup of amyloid plaques – harmful clumps of protein in the brain that are strongly linked to Alzheimer’s.

Weight loss injections reduce amyloid plaques and tau tangles

AD is characterized by amyloid plaques, which are a buildup of amyloid protein in the brain. This build-up can disrupt neural communication, increase inflammation and damage nerve cells.

Tau tangles are the build-up of the tau protein inside the nerve cell, which can lead to neuron death. These also play a significant role in AD and can cause cognitive decline.

GLP-1 RA may reduce the buildup of amyloid plaques and tau tangles, helping prevent neuron damage and death. GLP-1 RA may also promote the growth of new neurons, helping improve symptoms and slow disease progression.

While studies have shown promising results, one downside of taking GLP-1 RA as an AD patient is being underweight. The appetite-suppressing properties of GLP-1 RA can lead to serious health issues like nutrient deficiencies.

How can weight loss injections help Parkinson’s disease?

Parkinson’s disease (PD) is another type of dementia that primarily affects your motor skills, such as movement and balance. It’s caused by a loss of nerve cells that produce dopamine, causing motor-related symptoms like slow movements, bone problems and tremors. As the diseases worsen, it can lead to non-motor symptoms like depression, anxiety, sleep issues and memory problems.

Some studies have shown GLP-1 RA can restore dopamine levels, which may reverse the effects of PD and reduce symptoms.

Weight loss injections protect the dopaminergic neurons

Recent research shows GLP-1 RA may restore dopamine levels, which can help improve motor and non-motor related symptoms. Its neuroprotective properties may prevent further degradation of nerve cells that produce dopamine.

GLP-1 RAs effect on PD is inconclusive; some studies show promising results while others show no significant improvement in symptoms.

It’s important to note that most studies have a small sample size, so more research would be needed to investigate the relationship between GLP-1 RA and PD.

How can weight loss injections help reduce the risk of vascular dementia?

Vascular dementia is a type of dementia that’s caused by reduced blood flow to your brain. Some symptoms include memory loss, difficulty concentrating and trouble problem-solving.

GLP-1 RA might help treat vascular dementia by increasing blood flow to the brain and improving overall health.

Improved vascular health

Reduced blood flow to the brain deprives it of essential nutrients and oxygen needed for it to function properly. This deprivation can cause the brain cells to become damaged.

Research suggests that GLP-1 RA’s may help improve blood flow to the brain by relaxing and widening blood vessels. This increased blood flow can help deliver more oxygen and nutrients to brain tissue, which might help with symptoms of vascular dementia.

Additionally, since strokes are a major cause of vascular dementia, using a GLP-1 RA after a stroke could possibly reduce brain damage and potentially lower the risk of developing vascular dementia.

GLP-1 RA can also help manage blood pressure, blood sugar and total cholesterol level – all important for brain and heart health.

Improved mitochondrial function

Mitochondria are an important component in a cell that produces energy. Studies show mitochondrial dysfunction can increase oxidative stress, impair energy levels and affect neuronal cells, which all contribute to the development of vascular dementia.

GLP-1 RA may reduce oxidative stress, helping prevent damage and death of neuronal cells. It may also restore mitochondrial function and improve blood flow to the brain, further improving symptoms.

Could weight loss injections be used to help neurodegenerative diseases in the future?

GLP-1 RA may be used to treat and prevent neurodegenerative diseases. But not all GLP-1 RAs have the same benefit; the results can vary depending on the specific type of GLP-1 RA used.

While more research is needed, GLP-1 RA shows exciting potential to improve brain health and lower the risk of dementia.

Reference Popover #ref1
Reference Popover #ref2
Reference Popover #ref3
Reference Popover #ref4
Reference Popover #ref5
Reference Popover #ref6
Reference Popover #ref7
Reference Popover #ref8
Reference Popover #ref9
Reference Popover #ref10
Reference Popover #ref11

Sourcing guidelines:

When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.

Tell us what you want to hear.

Have a subject you’d like us to cover in a future article? Let us know.

Give us the inbox treatment.

We're making healthcare more about you. Sign up to our newsletter for personalized health articles that make a difference.

Disclaimer: The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment. If you have any questions or concerns about your health, please talk to a doctor.

Suggest a health guide

Tell us your idea here.

(And leave your email too, so we can let you know if we write an article based on your suggestion.)